Family Medicine · Jackson, MO
NPI
1740389980
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2387 W Jackson Blvd
Jackson, MO, 63755
Phone (573) 243-9288
Groups this clinician bills Medicare through
Medicare paid, 2024
$444K
24,849 services
Medicare patients, 2024
407
Average age 74
Drug cost, 2024
$1.3M
21,506 prescriptions
Company payments, 2025
$2,741
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles S Pewitt was code J1010 (injection, methylprednisolone acetate, 1 mg), 15,200 times for 133 patients. In total Charles S Pewitt billed 24,849 services in 48 codes, and Medicare paid $444K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 15,200 | 133 | $0.10 | $1,511 |
| 99214 Office E&M - Established | Office | 2,003 | 388 | $83.08 | $166K |
| 99458 E&M - Miscellaneous | Office | 1,470 | 74 | $27.86 | $41K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,314 | 210 | $42.81 | $56K |
| 99454 E&M - Miscellaneous | Office | 759 | 80 | $30.08 | $23K |
| 99457 E&M - Miscellaneous | Office | 759 | 81 | $32.87 | $25K |
| 99213 Office E&M - Established | Office | 529 | 246 | $59.62 | $32K |
| 96372 Injection Administration | Office | 440 | 177 | $9.34 | $4,111 |
| 93000 Electrocardiogram | Office | 347 | 317 | $9.12 | $3,163 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 340 | 340 | $16.46 | $5,597 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 268 | 261 | $38.32 | $10K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 264 | 264 | $118.74 | $31K |
| G0008 Administration of influenza virus vaccine | Office | 191 | 188 | $29.40 | $5,615 |
| 90661 Vaccine Product | Office | 189 | 189 | $36.11 | $6,825 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 126 | 37 | $0.35 | $43.54 |
By year: 2022 $577K for 14,002 services; 2023 $558K for 13,217 services; 2024 $444K for 24,849 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 600 | 349 | $8.40 | $5,040 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles S Pewitt prescribed most often to Medicare patients was Alprazolam, with 1,109 prescriptions and refills. In total Charles S Pewitt wrote 21,506 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 1,109 | 1,120 | 154 | $5,682 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 844 | 847 | 103 | $15K |
| Lisinopril Generic | 608 | 1,266 | 155 | $2,482 |
| Simvastatin Generic | 584 | 1,434 | 156 | $2,998 |
| Levothyroxine Sodium Generic | 516 | 1,031 | 116 | $3,721 |
| Atorvastatin Calcium Generic | 488 | 995 | 117 | $3,287 |
| Pantoprazole Sodium Generic | 465 | 855 | 114 | $4,196 |
| Amlodipine Besylate Generic | 437 | 844 | 110 | $1,789 |
| Hydrochlorothiazide Generic | 424 | 814 | 109 | $1,384 |
| Gabapentin Generic | 418 | 656 | 90 | $7,501 |
| Metformin Hcl Generic | 363 | 701 | 83 | $1,412 |
| Metoprolol Succinate Generic | 339 | 737 | 84 | $3,483 |
| Tramadol Hcl Generic | 335 | 335 | 62 | $2,847 |
| Meloxicam Generic | 324 | 576 | 85 | $1,200 |
| Allopurinol Generic | 315 | 713 | 72 | $2,415 |
Brand drugs: 1,931 claims; generic drugs: 19,488 claims; opioid claims: 1,393.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles S Pewitt $2,741 ($2,741 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $955.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 45 | $955 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 20 | $358 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $270 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $197 |
| Pfizer Inc. PFE | 12 | $147 |
| Esperion Therapeutics, Inc. ESPR | 5 | $109 |
| Lundbeck LLC | 4 | $90.38 |
| GlaxoSmithKline, LLC. GSK | 5 | $74.63 |
| Lilly USA, LLC LLY | 4 | $72.42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.